Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Cns Pharmaceuticals Inc logo

Cns Pharmaceuticals Inc

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

0.20
 
USD
  
0.00
  
(-0.20%)
Optionable: No  Market Cap: 2 M  90-day average vol: 436,187

Previous close: 0.2044  Open: 0.209  Bid: 0.21  Ask: 0.22
52 week range    
0.19   
   3.35
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 19th April 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

CNSP Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-17.1-15.9-11.22
Basic EPS total-17.1-15.9-11.22
Basic weighted shares outstanding454930.0553948.0878442.01 M
Depreciation unreconciled18082.0
DepreciationAndAmortization18082.0
Diluted EPS total-8.4-17.1-15.9-11.22
Diluted normalized net income/share-11.22
Diluted weighted shares outstanding461572.0553948.0878442.01 M
GeneralAndAdministrativeExpense2 M4 M5 M6 M
Income before tax-4 M-9 M-14 M-15 M
InterestExpenseNonOperating26152.03264.09285.07027.0
Net income from total operations-4 M-9 M-14 M-15 M
NetIncomeCommonStockholders-4 M-9 M-14 M-15 M
NetIncomeContinuousOperations-4 M-9 M-14 M-15 M
NetNonOperatingInterestIncomeExpense-26152.0-3264.0-9285.0-7027.0
NonRecurringOperationExpense100000.0
Normalized income-11 M-12 M
Operating income-4 M-9 M-14 M-15 M
Operating income before depreciation (EBITDA)-4 M-9 M-14 M-15 M
OperatingExpense-4 M9 M14 M15 M
OtherGandA2 M4 M5 M6 M
OtherOperatingExpenses14 M15 M
RentAndLandingFees2 M
Research & development expense2 M5 M10 M9 M
ResearchExpense2 M5 M10 M9 M
Revenue per share18082.0334138.0
SalariesAndWages-477096.01 M2 M1 M
Selling Gen & administrative expense2 M4 M5 M6 M
Special income/charges-100000.0
Total Income available for interest expense (EBIT)-4 M-9 M-14 M-15 M
Total common shares outstanding548341.0843362.01 M2 M
Total net income-4 M-9 M-14 M-15 M
Total ordinary shares5 M5 M5 M5 M
TotalExpenses-4 M9 M14 M15 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University